Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "innovation" return 116 results.
Ceva commits to helping improve preventative health strategies for Vietnam’s rapidly growing livestock sector >
Hanoi, Vietnam, 16 January 2020 - Ceva Santé Animale signed several agreements with the Vietnam Department of Animal Health (DAH) to accelerate the implementation of preventive health strategies, incl...
ProBioGen and Ceva Santé Animale sign an exclusive license agreement to produce vectorised poultry vaccines using AGE1.CR® production technology >
Berlin, Germany and Libourne, France 01st October 2019 - ProBioGen AG and Ceva Santé Animale announce the signature of an exclusive license agreement for the manufacture of vectorised poultry vaccines...
Ceva brings together international experts in human cardiology and veterinary to stimulate innovation >
Cardio Symposium Human - Veterinary 2019 (September 17 - Milan)
Ceva completes acquisition of IDT veterinary business assets, moving closer to its 2020 objective of 50:50 bio-pharma split >
Libourne & Dessau 3rd July 2019 - Ceva Santé Animale (“Ceva”) and IDT Biologika GmbH (“IDT”) today announced that they have successfully completed the acquisition of IDT’s veterinary biopharmaceutical...
Ceva Sante Animale makes Laval its global hub for innovation in the companion animal sector >
Laval, 25 June 2019 - Ceva, France’s largest veterinary biopharmaceutical company, has consolidated its investments in Mainland France, specifically in Laval, where it has established its global hub f...
Ceva Santé Animale and IDT Biologika GmbH announce agreement for Ceva to acquire the IDT animal health business, expanding its global vaccine portf... >
Libourne & Dessau 17th. May 2019 - Ceva Santé Animale (“Ceva”) and IDT Biologika GmbH (“IDT”) have reached a provisional agreement for Ceva to acquire IDT’s veterinary biopharmaceutical portfolio and...
Ceva Santé Animale announces the launch of ForcerisTM, the first approved injectable combination of gleptoferron and toltrazuril in Europe >
25th April 2019, Libourne – ForcerisTM received the first marketing authorisation from the European Medicines Agency (EMA) for this innovative combination of gleptoferron and toltrazuril to treat neon...
Ceva Poultry Innovation Summit focuses on sharing innovation along the value chain: from day-old chick to precision animal health >
10th April 2019, Libourne - 320 poultry veterinarians, production managers and other key opinion leaders from 50 countries across the world attended the Ceva Poultry Innovation Summit 2019. The event...
UK Ceva Animal Welfare Awards 2019 – winners announced! >
4 April 2019 The winners of the prestigious Ceva Animal Welfare Awards 2019 have been announced in a glittering ceremony in The Mercian Suite at the Birmingham Conference & Events Centre in Birmingham...
Ceva Chairman, Marc Prikazsky outlines how the human desire to improve the lives of children will continue to fuel future innovation >
12th March 2019, Libourne - Opening Ceva’s “C the future” Innovation summit ahead of Asia’s leading agricultural show, VIV Asia, Ceva Chairman & CEO, Marc Prikazsky said that the agricultural industry...